Published in Urology on May 01, 2015
What's new in screening in 2015? Curr Opin Urol (2016) 0.77
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Screening and prostate-cancer mortality in a randomized European study. N Engl J Med (2009) 35.94
Mortality results from a randomized prostate-cancer screening trial. N Engl J Med (2009) 30.05
Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev (2010) 12.60
Early detection of prostate cancer: AUA Guideline. J Urol (2013) 9.14
A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA (1995) 8.60
Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat (2013) 7.11
Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA (1993) 5.77
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat Rev Cancer (2008) 4.15
Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer Causes Control (2007) 2.69
Impact of comorbidity on survival among men with localized prostate cancer. J Clin Oncol (2011) 2.53
Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA (2014) 2.42
Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging. Urology (2001) 2.38
Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila) (2011) 2.19
Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer (2010) 2.13
Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population. Eur Urol (2011) 1.88
Screening for prostate cancer. CA Cancer J Clin (2009) 1.48
Prostate cancer in Asian men. Nat Rev Urol (2014) 1.46
Total and percent free prostate-specific antigen levels among U.S. men, 2001-2002. Cancer Epidemiol Biomarkers Prev (2005) 1.21
The Korean Heart Study: rationale, objectives, protocol, and preliminary results for a new prospective cohort study of 430,920 men and women. Eur J Prev Cardiol (2013) 1.08
Baseline prostate-specific antigen level and risk of prostate cancer and prostate-specific mortality: diagnosis is dependent on the intensity of investigation. Cancer Epidemiol Biomarkers Prev (2008) 0.92
Prostate-specific antigen and all-cause mortality: results from the Baltimore Longitudinal Study On Aging. J Natl Cancer Inst (2004) 0.82
Prostate-specific antigen and prostate cancer mortality: a systematic review. Am J Prev Med (2013) 0.80
PSA in benign prostatic hyperplasia and prostatic intraepithelial neoplasia. Urol Clin North Am (1993) 0.80
Mean sojourn time of preclinical gastric cancer in Korean men: a retrospective observational study. J Prev Med Public Health (2014) 0.90
Optimal Interval for Repeated Gastric Cancer Screening in Normal-Risk Healthy Korean Adults: A Retrospective Cohort Study. Cancer Res Treat (2015) 0.85
Distribution of dense breasts using screening mammography in Korean women: a retrospective observational study. Epidemiol Health (2014) 0.83
Rates of change to a positive result in subsequent screening mammography in Korean women: a retrospective observational study. J Prev Med Public Health (2014) 0.75
Kidney Function, Proteinuria, and Cancer Incidence: The Korean Heart Study. Am J Kidney Dis (2017) 0.75